|
Interferon Alfa-2b
|
|
Intron A
|
Interferon Alfa-2b Clinical Trials
- PEG-Interferon alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00045279 - Active, not recruiting
Stage IV Renal Cell Cancer
- Temozolomide plus PEG-Interferon alfa-2B in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00014261 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
ClinicalTrials.gov Identifier: NCT00134030 - Recruiting
localized osteosarcoma; metastatic osteosarcoma
- PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
Stage IV Renal Cell Cancer
- PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00049530 - Recruiting
Recurrent Melanoma; Stage IV Melanoma
- Zidovudine Levels in HIV Infected Patients Being Treated for HCV
ClinicalTrials.gov Identifier: NCT00059358 - Active, not recruiting
HIV Infections; Hepatitis C
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
ClinicalTrials.gov Identifier: NCT00402428 - Active, not recruiting
Chronic Hepatitis C
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
ClinicalTrials.gov Identifier: NCT00411385 - Active, not recruiting
Chronic Hepatitis C
- Triple Therapy with Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous HCV Non Responders
ClinicalTrials.gov Identifier: NCT00122629 - Terminated
Hepatitis C, Chronic
- Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
ClinicalTrials.gov Identifier: NCT00217373 - Recruiting
unspecified adult solid tumor, protocol specific
- PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy
ClinicalTrials.gov Identifier: NCT00215865 - Completed
Chronic Hepatitis C Virus Infection
- Vaccine Therapy Plus Interleukin-2 With or Without Interferon alfa-2b in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00004104 - Active, not recruiting
stage III melanoma
- Interferon alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
ClinicalTrials.gov Identifier: NCT00003444 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Interferon alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
ClinicalTrials.gov Identifier: NCT00004196 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
ClinicalTrials.gov Identifier: NCT00253474 - Active, not recruiting
Neoplasm of Uncertain Malignant Potential; Unspecified Childhood Solid Tumor, Protocol Specific
- The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients with Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00001114 - Completed
Sarcoma, Kaposi; HIV Infections
- Interferon alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
ClinicalTrials.gov Identifier: NCT00005966 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00238329 - Active, not recruiting
Intraocular Melanoma; Melanoma (Skin)
- Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer
ClinicalTrials.gov Identifier: NCT00138151 - Recruiting
recurrent cervical cancer; stage IVB cervical cancer
- Sunitinib Malate Alone and in Combination With Interferon Alfa as First-Line Therapy for Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00267748 - Recruiting
Renal Cell Carcinoma
- Interferon Alfa in Treating Children With HIV-Related Cancer
ClinicalTrials.gov Identifier: NCT00002621 - Active, not recruiting
Leukemia; Lymphoma
- Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00176527 - Active, not recruiting
Prostate Cancer
- Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
ClinicalTrials.gov Identifier: NCT00117533 - Recruiting
Chronic Hepatitis B; Chronic Hepatitis D
- Azacitidine and Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00217542 - Recruiting
Stage III melanoma; Stage IV Melanoma; Stage IV Renal Cell Cancer; recurrent renal cell cancer; Recurrent Melanoma
- PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
ClinicalTrials.gov Identifier: NCT00052650 - Recruiting
adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain stem glioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
- Interferon alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00072046 - Active, not recruiting
Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
- Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN alfa-2b), and Ribavirin (RBV) Treatment in Patients with Hepatitis C and HIV Coinfection
ClinicalTrials.gov Identifier: NCT00015652 - Completed
HIV Infections; Hepatitis C
- Sodium Stibogluconate and Interferon Alfa-2b Followed By Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Advanced Melanoma or Other Cancer
ClinicalTrials.gov Identifier: NCT00498979 - Recruiting
Brain and Central Nervous System Tumors; Melanoma (Skin)
- Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00467077 - Recruiting
Kidney Cancer
- Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00471484 - Recruiting
Liver Cancer
- Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00040027 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- Long-Term Evaluation Follow-Up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C Infection and a Former (Peg)Interferon Alfa-2b-Based Therapy
ClinicalTrials.gov Identifier: NCT00227149 - Recruiting
Hepatitis C, Chronic
- Combination Chemotherapy Plus Interferon alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
ClinicalTrials.gov Identifier: NCT00004039 - Active, not recruiting
Lymphoma
- Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
ClinicalTrials.gov Identifier: NCT00002657 - Active, not recruiting
Lymphoma; Multiple Myeloma
- An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
ClinicalTrials.gov Identifier: NCT00489385 - Recruiting
HIV Infections; HCV
- Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00002504 - Active, not recruiting
Lymphoma; Leukemia
- Interferon alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
ClinicalTrials.gov Identifier: NCT00002965 - Active, not recruiting
recurrent adult brain tumor
- Interferon alfa Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00006249 - Active, not recruiting
stage III melanoma
- Combination Chemotherapy With or Without Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003027 - Active, not recruiting
Stage IV Melanoma
- Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
primary systemic amyloidosis
- Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00561912 - Recruiting
Renal Cell Carcinoma
- A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
ClinicalTrials.gov Identifier: NCT00087633 - Active, not recruiting
Hepatitis C
- Bevacizumab and PEG-Interferon alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
ClinicalTrials.gov Identifier: NCT00055809 - Completed
recurrent gastrointestinal carcinoid tumor; metastatic gastrointestinal carcinoid tumor; regional gastrointestinal carcinoid tumor
- Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
ClinicalTrials.gov Identifier: NCT00078442 - Active, not recruiting
HIV Infections
- Interferon alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00002882 - Active, not recruiting
stage III melanoma
- A Phase I Trial of Peginterferon alfa-2b (PEG-Intron) for Plexiform Neurofibromas
ClinicalTrials.gov Identifier: NCT00156754 - Recruiting
- Combination Chemotherapy, Interferon alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002669 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interferon alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00053820 - Active, not recruiting
Stage IV Renal Cell Cancer
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients with Hepatitis C
ClinicalTrials.gov Identifier: NCT00118768 - Active, not recruiting
Chronic Hepatitis C
- Vaccine Therapy Compared With Interferon alfa in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00003715 - Active, not recruiting
stage III melanoma
- Interleukin-12 Followed by Interferon alfa in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00003451 - Active, not recruiting
Cancer
- Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00003263 - Active, not recruiting
localized malignant mesothelioma
- Efficacy of Prazosin Versus Placebo Associated with Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C with Genotype 1 or 4 and Severe Fibrosis
ClinicalTrials.gov Identifier: NCT00148837 - Active, not recruiting
Hepatitis C, Chronic; Fibrosis
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
ClinicalTrials.gov Identifier: NCT00569127 - Not yet recruiting
Head and Neck Cancer; Islet Cell Tumor; Neuroendocrine Carcinoma of the Skin
- Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590)
ClinicalTrials.gov Identifier: NCT00378599 - Recruiting
Liver Transplantation; Hepatitis C, Chronic; Liver Cirrhosis
- SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00083889 - Active, not recruiting
Renal Cell Carcinoma
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
chronic phase chronic myelogenous leukemia
- Thymosin Plus PEG-Interferon in Hepatitis C Patients with Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00039962 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron™ (Trademark)) in Children with Diffuse Pontine Gliomas
ClinicalTrials.gov Identifier: NCT00036569 - Recruiting
Glioma
- Tretinoin Plus Interferon alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003656 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interferon alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00062010 - Active, not recruiting
Recurrent Small Cell Lung Cancer
- PEG-Interferon alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00085384 - Suspended
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Interferon alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002767 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; Quality of Life
- SU5416 and Interferon alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00006384 - Completed
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interferon alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00027664 - Recruiting
Stage IV Renal Cell Cancer
- Oblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00059813 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
ClinicalTrials.gov Identifier: NCT00019474 - Active, not recruiting
Pancreatic Cancer; Gastric Cancer; adult primary liver cancer
- Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002847 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- High-Dose or Low-Dose Interferon alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00002763 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Bevacizumab With or Without Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026221 - Recruiting
Stage IV Melanoma; Recurrent Melanoma
- Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Interleukin-2, Interferon alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
ClinicalTrials.gov Identifier: NCT00053807 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Interferon alfa Plus Radiation Therapy in Treating Patients With Stage III or Recurrent Melanoma That Has Been Removed by Surgery
ClinicalTrials.gov Identifier: NCT00005615 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Interferon alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non- Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003924 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Short-Term Low-Dose Interferon alfa in Treating Patients With Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00082719 - Recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Isotretinoin, Interferon alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00054561 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
- Cisplatin, Gemcitabine, Interferon alfa, and Hyperthermia in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00004063 - Recruiting
unspecified adult solid tumor, protocol specific
- Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00059826 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- High-Dose Interferon alfa in Treating Patients With Stage II or Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00003641 - Recruiting
stage II melanoma; stage III melanoma
- Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00085436 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
ClinicalTrials.gov Identifier: NCT00000844 - Completed
HIV Infections
- A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00000694 - Completed
Sarcoma, Kaposi; HIV Infections
- Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00015912 - Active, not recruiting
recurrent grade I follicular small cleaved cell lymphoma; recurrent grade II follicular mixed cell lymphoma
- PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML
ClinicalTrials.gov Identifier: NCT00303290 - Active, not recruiting
Chronic Myeloid Leukemia
- Temozolomide and Interferon alfa in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00027742 - Active, not recruiting
iris melanoma; extraocular extension melanoma; recurrent intraocular melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Advanced Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00065468 - Active, not recruiting
Carcinoma, Renal Cell; Kidney Neoplasms
- Vaccine Therapy, Interferon alfa, and Cyclophosphamide in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00095862 - Recruiting
recurrent breast cancer; stage IV breast cancer
- Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Allogeneic Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00055874 - Recruiting
chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
- Interferon alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00045422 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
- Combination Chemotherapy Followed By Antiviral Therapy and Interferon alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma
ClinicalTrials.gov Identifier: NCT00041327 - Active, not recruiting
stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; stage III adult T-cell leukemia/lymphoma; ...
- Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon alfa in Treating Patients With Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00002734 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Efficacy of Pegylated Interferon On Liver Fibrosis in Co-Infected Patient with HIV and C Hepatitis Who Failed to Active Treatment for HCV
ClinicalTrials.gov Identifier: NCT00122616 - Active, not recruiting
HIV Infections; Hepatitis C, Chronic
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00004244 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Stage IV Melanoma; Recurrent Melanoma
- Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplantation Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00016887 - Active, not recruiting
stage III mantle cell lymphoma; stage IV mantle cell lymphoma
- A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00001113 - Completed
Sarcoma, Kaposi; HIV Infections
- Sorafenib and Interferon alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00098618 - Active, not recruiting
recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma; renal granular cell carcinoma
- Interferon alfa in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003542 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
